IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.322
EU - Europa 20.517
AS - Asia 17.927
SA - Sud America 3.776
AF - Africa 591
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 44
Totale 79.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.740
CN - Cina 6.310
SG - Singapore 5.496
IT - Italia 5.117
UA - Ucraina 3.998
DE - Germania 3.400
BR - Brasile 3.112
HK - Hong Kong 2.373
PL - Polonia 1.832
FR - Francia 1.257
VN - Vietnam 1.239
FI - Finlandia 1.167
RU - Federazione Russa 1.021
GB - Regno Unito 982
TR - Turchia 714
IE - Irlanda 697
IN - India 473
BD - Bangladesh 401
CA - Canada 280
AR - Argentina 262
SE - Svezia 226
NL - Olanda 193
MX - Messico 182
ES - Italia 160
IQ - Iraq 138
ZA - Sudafrica 131
NG - Nigeria 129
ID - Indonesia 116
MA - Marocco 104
EC - Ecuador 102
JP - Giappone 102
CO - Colombia 84
PK - Pakistan 67
AT - Austria 65
AU - Australia 61
SA - Arabia Saudita 55
VE - Venezuela 55
UZ - Uzbekistan 53
PY - Paraguay 45
CL - Cile 44
EG - Egitto 44
BE - Belgio 42
IL - Israele 42
CZ - Repubblica Ceca 41
EU - Europa 41
JO - Giordania 36
KE - Kenya 35
RO - Romania 35
TN - Tunisia 35
CH - Svizzera 34
DZ - Algeria 34
UY - Uruguay 33
LT - Lituania 31
KZ - Kazakistan 29
JM - Giamaica 27
AL - Albania 26
NP - Nepal 26
PH - Filippine 26
EE - Estonia 25
LB - Libano 25
AE - Emirati Arabi Uniti 23
GR - Grecia 21
TH - Thailandia 21
IR - Iran 20
KR - Corea 20
PE - Perù 20
AZ - Azerbaigian 19
DK - Danimarca 17
PT - Portogallo 17
ET - Etiopia 16
HU - Ungheria 16
BO - Bolivia 15
DO - Repubblica Dominicana 15
SK - Slovacchia (Repubblica Slovacca) 15
SN - Senegal 15
TW - Taiwan 14
HN - Honduras 13
CR - Costa Rica 12
MU - Mauritius 12
TT - Trinidad e Tobago 12
MK - Macedonia 11
BG - Bulgaria 10
LY - Libia 9
MY - Malesia 9
NO - Norvegia 9
PS - Palestinian Territory 9
RS - Serbia 9
KG - Kirghizistan 8
LU - Lussemburgo 8
LV - Lettonia 8
PA - Panama 8
BH - Bahrain 7
BY - Bielorussia 7
GE - Georgia 7
GT - Guatemala 7
KW - Kuwait 7
SV - El Salvador 7
NZ - Nuova Zelanda 6
OM - Oman 6
AM - Armenia 5
Totale 79.140
Salva come PNG Salva come JPEG
Città #
Fairfield 4.277
Woodbridge 3.986
Singapore 2.890
Jacksonville 2.814
Ashburn 2.759
Houston 2.750
Hong Kong 2.347
Warsaw 1.806
Ann Arbor 1.736
Seattle 1.640
Cambridge 1.639
Wilmington 1.514
The Dalles 1.418
Beijing 1.251
Princeton 1.213
San Jose 1.093
Nanjing 932
Chandler 752
New York 742
Dublin 631
Helsinki 624
Istanbul 572
Lauterbourg 552
Los Angeles 552
Milan 504
Ho Chi Minh City 421
Nanchang 353
Buffalo 316
Des Moines 303
São Paulo 288
Moscow 263
Hanoi 260
Rome 253
Shenyang 251
Munich 246
San Diego 235
Changsha 233
Hebei 230
Dallas 228
Brescia 224
Redondo Beach 191
Tianjin 173
Shanghai 162
Jiaxing 148
London 148
Chicago 146
San Francisco 146
Lancaster 138
Jinan 133
Abuja 124
Verona 123
Florence 121
Santa Clara 116
Council Bluffs 114
Hangzhou 102
Nürnberg 102
Rio de Janeiro 102
Orem 96
Kunming 88
Chennai 84
Tokyo 84
Turku 79
Nuremberg 78
Guangzhou 74
Toronto 73
Bologna 70
Johannesburg 70
Turin 70
Frankfurt am Main 68
Brooklyn 64
Belo Horizonte 62
Dearborn 60
Trieste 60
Montreal 59
Phoenix 59
Zhengzhou 59
Boardman 58
Baghdad 57
Mexico City 55
Porto Alegre 54
Amsterdam 52
Atlanta 51
Dhaka 51
Lanzhou 51
Mumbai 51
Ningbo 50
Brasília 49
Kocaeli 49
Curitiba 48
Haiphong 48
Paris 48
Bergamo 47
Da Nang 47
Dong Ket 47
Poplar 46
Tashkent 46
Denver 44
Manchester 44
Genoa 43
Barcelona 42
Totale 49.922
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.382
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.837
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 1.470
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 340
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 314
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 312
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 303
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 295
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 285
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 256
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 250
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 239
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 233
Long-term outcome of children of rheumatic disease patients 233
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 232
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 231
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 228
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 221
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 210
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 208
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 207
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 205
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 204
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 201
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 196
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 195
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 195
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 195
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 193
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 193
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 191
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 190
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 189
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 189
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 186
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 184
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 184
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 184
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 184
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 183
Anti-phospholipid antibodies 182
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 181
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 180
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 180
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 180
Children born to SLE and APS mothers 179
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 178
New acquirements on an old molecule: type I interferon. 177
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 177
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 177
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 176
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 174
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 173
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 171
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 171
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 169
Antiphospholipid antibodies mediate autoimmunity against dying cells. 169
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension 169
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 169
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 169
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 169
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 168
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 168
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 168
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 168
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 167
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 164
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 164
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 163
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 162
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 162
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 160
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 158
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 157
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 157
Pregnancy complications of the antiphospholipid syndrome 156
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 156
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 156
Autoimmune polyendocrine Syndromes 155
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 155
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 154
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 154
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 153
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 153
Long-term outcome of children born from mothers with autoimmune diseases 153
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 152
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 151
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 150
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 150
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 150
V meeting of the European forum on antiphospholipid antibodies. 149
Impact of in utero environment on the offspring of lupus patients 149
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 149
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 149
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 149
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 149
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 149
Totale 23.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 366.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 366.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 0 0 364
2021/20225.224 279 978 159 312 145 300 317 393 289 556 468 1.028
2022/20233.583 701 46 82 180 281 995 41 288 517 54 206 192
2023/20244.334 235 124 327 346 191 637 156 180 1.244 108 90 696
2024/202510.258 141 131 102 1.184 1.088 918 934 405 866 1.148 2.099 1.242
2025/202619.590 1.792 2.881 1.666 3.190 1.738 1.194 2.712 711 1.112 1.603 695 296
Totale 80.113